📖

DOT1L Gene

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-dot1l

Related Entities

Metadata

slug	genes-dot1l
entity_type	gene
kg_node_id	DOT1L

🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (89)

see_also📖Epigenetic Clocks in Neurodegeneration — Causal Drivers or P60%

see_also📖APP Gene Dosage Reduction Therapy for Down Syndrome60%

see_also📖ABCB1 (MDR1) - ATP Binding Cassette Subfamily B Member 160%

see_also📖Alpha-Synuclein Seed Kinetic Staging in Parkinson's Dis60%

see_also📖dopaminergic-vta-pd60%

see_also📖Dorsal Raphe Serotonergic Neurons in Parkinson's Diseas60%

see_also📖Globus Pallidus Internus in Parkinsons Disease60%

see_also📖Melanocytes in Parkinson Disease60%

see_also📖Nigrostriatal Dopamine Terminals in Parkinson's Disease60%

see_also📖Dopaminergic Substantia Nigra Neurons in Parkinson's Di60%

see_also📖Vulnerable Dopaminergic Neurons in Parkinson's Disease60%

see_also📖AB-1005 (REGENERATE-PD) GDNF Gene Therapy Trial60%

see_also📖ABBV-951 (foslevodopa/foscarbidopa) for Parkinson's Dis60%

see_also📖Apocynin for Parkinson's Disease60%

see_also📖Bacillus Subtilis for Parkinson Disease (NCT06487975)60%

see_also📖biib122-luma-lrrk2-inhibitor-pd60%

see_also📖CT1-DAP001 iPS Cell-derived Dopaminergic Progenitors for Par60%

see_also📖CVN424 Phase 3 ARISE Trial for Parkinson's Disease60%

see_also📖Intranasal Insulin and Glutathione for PD (NOSE-PD)60%

see_also📖NCT05565443: MR-Guided Focused Ultrasound + GCase for Parkin60%

see_also📖nct05266417-nose-pd60%

see_also📖nct06365190-rtms-pd60%

see_also📖NCT06487975: Bacillus Subtilis Gut Microbiome Intervention f60%

see_also📖Autologous Stem Cell-Derived Dopaminergic Neurons for Parkin60%

see_also📖Dyadic Mindfulness for PD Carers (NCT06821230)60%

see_also📖Amino Acid Supplement in Parkinson's Disease (NCT06954660%

see_also📖Vibrotactile Stimulation Walking Speed PD Trial60%

see_also📖Noradrenergic Arousal System Phase 3 PD Trial (NCT07316296)60%

see_also📖tDCS + Nordic Walking for Parkinson's Disease Motor Sym60%

see_also📖NouvNeu001 Cell Therapy for Parkinson's Disease60%

see_also📖PDE4 Inhibitor PD Trial60%

see_also📖Retigabine PD Trial60%

see_also📖Valacyclovir for HSV-1-Positive Parkinson's Disease60%

see_also📖NCT05881460: Vibrotactile Coordinated Reset for Parkinson&#x60%

see_also📖AMP-PD: Accelerating Medicines Partnership: Parkinson's60%

see_also📖Alpha-Synuclein SAA Kinetics Study — Biological Staging Back60%

see_also📖Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio60%

see_also📖Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation60%

see_also📖Combination Therapy Sequencing in Parkinson's Disease60%

see_also📖Selective Vulnerability of Dopaminergic Neurons — Mechanism 60%

see_also📖GLP-1 Agonist Responder Prediction Study — Precision Medicin60%

see_also📖Non-Motor Symptom Progression in Parkinson's Disease — 60%

see_also📖Synaptic Mitochondrial Resilience Enhancement for Parkinson&60%

see_also📖Accelerating Medicines Partnership for Alzheimer's Dise60%

see_also📖Accelerating Medicines Partnership for Parkinson's Dise60%

see_also📖Fibrinogen and αVβ3 Integrin in Alpha-Synuclein Pathology60%

see_also📖MLCS Quantification Methods in Parkinson's Disease Rese60%

see_also📖Pallido-Thalamocortical Motor Pathway in Parkinson's Di60%

see_also📖PDLIM7 Epigenetic Activation in Parkinson's Disease60%

see_also📖SAA and Imaging for Prodromal Parkinson's Disease Trial60%

see_also📖AI-Powered Movement Analysis for Parkinson's Disease60%

see_also📖Digital Biomarker Platforms for Parkinson's Disease60%

see_also📖Digital Therapeutics for Parkinson's Disease60%

see_also📖Wearable Sensors for Parkinson's Disease60%

see_also📖Adenosine A2A Receptor Antagonists60%

see_also📖CUE1 Non-Invasive Vibrotactile Device for Parkinson's D60%

see_also📖Neurorestore Therapies for Parkinson's Disease60%

see_also📖Synaptic Plasticity Therapeutics for Parkinson's Diseas60%

see_also📖AMPK (AMP-Activated Protein Kinase)60%

see_also📖cd1460%

see_also📖DNMT3A Gene60%

see_also📖Packard Center for ALS Research60%

mentions🧪PARP1 Inhibition Therapy50%

mentions🧪Extracellular Matrix Stiffness Modulation50%

mentions🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors50%

mentions🧪Circadian Clock-Autophagy Synchronization50%

mentions🧪Astrocyte-Mediated Neuronal Epigenetic Rescue50%

mentions🧪CYP46A1 Overexpression Gene Therapy50%

mentions🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th50%

related🔬What are the mechanisms underlying neuroinflammation resolut50%

related🔬Investigate how lipid raft composition (cholesterol metaboli50%

related🔬What are the mechanisms underlying neuroinflammation resolut50%

related🔬Investigate how lipid raft composition (cholesterol metaboli50%

related🔬Analyze circuit-level changes in neurodegeneration using All50%

related🧪Temporal Decoupling via Circadian Clock Reset50%

related🧪Senescence-Induced Lipid Peroxidation Spreading50%

related🧪Senescence-Associated Myelin Lipid Remodeling50%

related🧪Senescence-Activated NAD+ Depletion Rescue50%

related🧪DNMT1-Targeting Antisense Oligonucleotide Reset50%

related🧪KDM6A-Mediated H3K27me3 Rejuvenation50%

related🧪Temporal TET2-Mediated Hydroxymethylation Cycling50%

related🧪Epigenetic Memory Erasure via TET2 Activation50%

related🧪TET2-Mediated Demethylation Rejuvenation Therapy50%

related🧪Perforant Path Presynaptic Terminal Protection Strategy50%

related🧪Digital Twin-Guided Metabolic Reprogramming50%

related🔬What are the mechanisms underlying tdp-43 phase separation t50%

mentions🔬Analyze circuit-level changes in neurodegeneration using All40%

related🧪CYP46A1 Overexpression Gene Therapy40%

related🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th40%